美国血浆采集市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

美国血浆采集市场 – 行业趋势及 2031 年预测

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Country Level
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>美国血浆采集市场,按类型(回收血浆和源血浆)、产品类型(针头和注射器、采集管等)、方法(自动血浆采集和手动血浆采集)、应用(分子生物学、样品回收、血糖分析、血液学分析等)、最终用户(医院、病理实验室和诊断中心、血库等)划分 - 行业趋势和预测到 2031 年。

 美国血浆采集市场分析及规模

在血浆采集市场,自动化采集技术的进步提高了效率,确保血浆成分的精确分离和采集。创新还解决了捐献者不适等挑战,提高了捐献率。这些发展有助于简化和提高血浆采集过程,使捐献者和医疗机构都受益。                

Data Bridge Market Research 分析称,美国血浆采集市场在 2023 年为 51.8 亿美元,预计到 2031 年将达到 84.4 亿美元,预计在 2024 年至 2031 年的预测期内复合年增长率为 6.3%。这表明市场价值。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

美国血浆采集市场范围和细分

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

类型(回收血浆和源血浆)、产品类型(针头和注射器、采集管等)、方法(自动血浆采集和手动血浆采集)、应用(分子生物学、样本回收、血糖分析、血液学分析等)、最终用户(医院、病理实验室和诊断中心、血库等)

涵盖的市场参与者

STRECK(美国)、SIO2 Material Science(美国)、Grifols(西班牙)、Instech Laboratories, Inc.(美国)、CSL Plasma(澳大利亚)、Greiner Bio-One International GmbH(奥地利)、Cardinal Health(美国)、Retractable Technologies, Inc.(美国)、BD(美国)、Bio Products Laboratory Ltd.(美国)、Hemarus Plasma(美国)、Liminal Biosciences, Inc.(加拿大)、Vitalant(美国)、武田药品工业株式会社(日本)、Octapharma AG(瑞士)、Kedrion(意大利)

市场机会

  • 慢性病患病率上升带来治疗需求
  • 加强血浆捐献的公共卫生举措

市场定义

血浆采集包括通过血浆分离术从捐献者体内提取血浆(血液中含有蛋白质的液体部分)。捐献者被连接到一台机器上,该机器将血浆与其他血液成分分离,并将红细胞和血小板返回捐献者体内。然后血浆可用于各种医疗和疗法。            

美国血浆采集市场动态

驱动程序

  • 老龄人口增加创造需求

全球老年人口的增长推动了血浆衍生产品的需求,因为老年人更容易患上需要治疗的疾病。老年人需要血浆疗法的疾病发病率较高,这凸显了收集血浆以满足医疗保健需求和满足老年人口特定医疗需求的需求日益增长。

  • 政府对产品安全和质量的举措

支持性监管框架确保血浆衍生产品的安全性和质量,增强利益相关者的信心并推动市场增长。严格的法规管理血浆的采集、加工和分配,确保遵守安全标准。这种监管环境增强了消费者和医疗保健专业人士之间的信任,有助于扩大血浆采集市场。

机会

  • 慢性病患病率上升带来治疗需求

癌症、肝病和神经系统疾病等慢性病发病率不断上升,推动了血浆采集需求的增加。由于这些疾病通常需要血浆疗法进行治疗,患病率的上升凸显了扩大和高效血浆采集结构以满足日益增长的治疗需求的迫切需求。

  • 加强 血浆捐献的公共卫生举措

倡导血浆捐献的公共卫生运动,加上补偿或捐赠者奖励等激励措施,刺激了更多人参与。这些举措提高了人们对血浆采集对于挽救生命的治疗的重要性的认识,激励个人做出贡献。通过激励捐赠,社区可以增加血浆供应,确保有需要的人能够获得关键治疗。

限制/挑战

  • 血浆捐献者数量有限,影响血浆供应

由于合格捐献者数量有限,血浆采集市场面临巨大挑战。这种稀缺性导致血浆供应波动不可预测,阻碍了市场的可扩展性。在没有直接解决方案的情况下,不断扩大捐献者群体的斗争构成了巨大障碍,影响了市场满足日益增长的血浆衍生产品需求的能力。 

  • 新进入者的投资成本高

The high capital investment required for establishing plasma collection centers acts as a formidable barrier, restricting new entrants and impeding market growth. This financial burden encompasses infrastructure development, acquisition of specialized equipment, and the recruitment and training of personnel. Consequently, this financial barrier limits competition, constrains market expansion, and hampers the overall development of the blood plasma collection market. 

This U.S. blood plasma collection market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the U.S. blood plasma collection market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In June 2021, Cardinal Health Nuclear & Precision Health Solutions secured FDA approval for LYMPHOSEEK Paediatric Indication, propelling company growth in the blood plasma collection market, with expanded offerings catering to pediatric patients, strengthening market demand and revenue
  • In June 2021, Octapharma AG's octagam gained European and German approvals for dermatomyositis in adults, augmenting the company's presence in the blood plasma collection market, particularly in Europe and Germany. This diversification strengthens market competitiveness and revenue potential
  • In May 2020, Grifols, S.A. commenced plasma collection from COVID-19 recovered patients, fueling growth in the blood plasma collection market by facilitating the development of hyperimmune globulin for potential coronavirus treatment. This initiative drives market expansion through innovative therapeutic solutions
  • In April 2020, Octapharma AG established a specialized team to explore COVID-19 therapies and collaborated with plasma fractionation leaders to develop plasma-derived hyperimmune immunoglobulin therapy for COVID-19 treatment. This collaboration stimulates growth in the blood plasma collection market by fostering innovation and addressing urgent healthcare needs

U.S. Blood Plasma Collection Market Scope

The U.S. blood plasma collection market is segmented on the basis of type, product type, method, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Recovered Plasma
  • Source Plasma

 Product Type

  • Needles and Syringes
  • Collection Tubes
  • Others

 Method

  • Automated Plasma Collection
  • Manual Plasma Collection

 Application

  • Molecular Biology
  • Sample Recovery
  • Blood Glucose Analysis
  • Hematological Analysis
  • Others

 End User

  • Hospitals
  • Pathology Labs and Diagnostic Centers
  • Blood Banks
  • Others

U.S. Blood Plasma Collection Market Regional Analysis/Insights

The U.S. blood plasma collection market is analysed and market size insights and trends are provided by country, type, product type, method, application and end user as referenced above.

The countries covered in the U.S. blood plasma collection market report is U.S.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The U.S. blood plasma collection market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for U.S. blood plasma collection market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the U.S. blood plasma collection market. The data is available for historic period 2016-2021.

Competitive Landscape and U.S. Blood Plasma Collection Market Share Analysis

The U.S. blood plasma collection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to U.S. blood plasma collection market.

Some of the major players operating in the U.S. blood plasma collection market are:

  • STRECK (U.S.)
  • SIO2 Material Science (U.S.)
  • Grifols (Spain)
  • Instech Laboratories, Inc. (U.S.)
  • CSL Plasma (Australia)
  • Greiner Bio-One International GmbH (Austria)
  • Cardinal Health (U.S.)
  • Retractable Technologies, Inc. (U.S.)
  • BD (U.S.)
  • Bio Products Laboratory Ltd. (U.S.)
  • Hemarus Plasma (U.S.)
  • Liminal Biosciences, Inc. (Canada)
  • Vitalant (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Octapharma AG (Switzerland)
  • Kedrion (Italy)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The U.S. blood plasma collection market size will be worth USD 8,289.06 million by 2031.
The growth rate of the U.S. blood plasma collection market is 6.3% during the forecast period by 2031.
The increasing aging population creates demand & government initiatives for safety and quality of product are the growth drivers of the U.S. blood plasma collection market.
Type, product type, method, application and end-user are the factors on which the U.S. blood plasma collection market research is based.
Major companies in the U.S. blood plasma collection market are STRECK (U.S.), SIO2 Material Science (U.S.), Grifols (Spain), Instech Laboratories, Inc. (U.S.), CSL Plasma (Australia), Greiner Bio-One International GmbH (Austria), Cardinal Health (U.S.), Retractable Technologies, Inc. (U.S.), BD (U.S.), Bio Products Laboratory Ltd. (U.S.), Hemarus Plasma (U.S.), Liminal Biosciences, Inc. (Canada), Vitalant (U.S.), Takeda Pharmaceutical Company Limited (Japan), Octapharma AG (Switzerland), Kedrion (Italy).